This headline turned heads across the diabetes landscape:
“CITY OF HOPE SETS NEW GOAL FOR TYPE 1 DIABETES CURE
More than $50 million in private funding…
Category: Science
Last week, Lucy Hinchion, aged 20 months, became the youngest child in the world to receive her own cord blood to help prevent or delay the onset of…
Working toward a better life – and a cure – for any disease is a practice in patience. We all start out hoping for some “Lorenzo’s Oil” type of situation:…
A couple of weeks ago I sat down with Dr. Francisco Quintana, who runs a lab at Brigham and Women’s Hospital in Boston focused on finding new treatments…
The diabetes community has been here before, and in the late 1980’s, had the same outcry. We want a cure! JDRF (JDF at the time) listened, embraced the movement, and gave it a name: TORIAC
The initial study, which will start enrolling next year, will involve about ten patients, who will have the stem-cell derived beta cells injected into their forearms, in the hopes that the cells will start producing insulin within the body.
But here’s the thing: this is not one product. This is not one moment in time. This is an entire new generation of tools and treatment, and it needs an umbrella name for it all to be grouped under. JDRF called it the APP – Artificial Pancreas Project – because it is just that. A project. A mission. Not just one finite goal.
The 670G actually uses data from the sensor to give you insulin. This is an enormous step toward a genuine closed loop/artificial pancreas system, and is a really big deal.
On a February morning in 1962, astronaut John Glenn was launched into space to orbit the earth. The world watched in wonder, imagining what could…
Medtronic announced on June 27 that it has submitted its Hybrid Closed Loop System (otherwise known as the MMT-670G system) to the FDA for approval. While not technically an artificial pancreas, the system consists of two parts: an insulin pump and a continuous glucose monitor. Once the system has been calibrated, the pump uses the readings from the CGM (which are taken every five minutes) to deliver insulin, with the goal of keeping blood sugars within a target range.